Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation

S. Noble and J. A. Balfour, Meloxicam, Drugs 51 (1996) 424-430; DOI: 10.2165/00003495-199651030-00007.10.2165/00003495-199651030-00007Search in Google Scholar

N. M. Davies and N. M. Skjodt, Clinical pharmacokinetics of meloxicam: a cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug, Clin. Pharmacokinet. 36 (1999) 115-126; DOI: 2165/00003088-199936020-00003.Search in Google Scholar

B. J. Gates, T. T. Nguyen, S. M. Setter and N. M. Davies, Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety, Expert Opin. Pharmacother. 6 (2005) 2117-2140; DOI: 10.1517/14656566.6.12.2117.10.1517/14656566.6.12.2117Search in Google Scholar

M. R. Prausnitz, S. Mitragotri and R. Langer, Current status and future potential of transdermal drug delivery, Nat. Rev. Drug Discov. 3 (2004) 115-124; DOI: 10.1038/nrd1304.10.1038/nrd1304Search in Google Scholar

E. Beetge, J. D. Plessis, D. G. Muller, C. Goosen and F. J. Van Rensburg, The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAIDs on their transdermal absorption, Int. J. Pharm. 193 (2000) 261-264; DOI: 10.1016/S0378-5173(99)00340-3.10.1016/S0378-5173(99)00340-3Search in Google Scholar

P. Stei, B Kruss, J. Weigleb and V. Trach, Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration, Br. J. Rheumatol. 35 (1996) 44-50; DOI: 10.1093/rheumatology/35.suppl_1.44.10.1093/rheumatology/35.suppl_1.44Search in Google Scholar

R. Jantharaprapap and G. Stagni, Effects of penetration enhancers on in vitro permeability of meloxicam gels, Int. J. Pharm. 343 (2007) 26-33; DOI: 10.1016/j.ijpharm.2007.04.011.10.1016/j.ijpharm.2007.04.011Search in Google Scholar

J. S. Chang, Y. B. Huang, S. S. Hou, R. J. Wang, P. C. Wu and Y. H. Tsai, Formulation optimization of meloxicam sodium gel using response surface methodology, Int. J. Pharm. 338 (2007) 48-54; DOI: 10.1016/j.ijpharm.2007.01.033.10.1016/j.ijpharm.2007.01.033Search in Google Scholar

Y. Yuan, S. M. Li, F. K. Mo and D. F. Zhong, Investigation of microemulsion system for transdermal delivery of meloxicam, Int. J. Pharm. 321 (2006) 117-123; DOI: 10.1016/j.ijpharm.2006.06.021.10.1016/j.ijpharm.2006.06.021Search in Google Scholar

ICH Q2 (R1) Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva 2005, Switzerland.Search in Google Scholar

M. Joshi and V. Patravale, Nanostructured lipid carrier (NLC) based gel of celecoxib, Int. J. Pharm. 346 (2008) 124-132; DOI: 10.1016/j.ijpharm.2007.05.060.10.1016/j.ijpharm.2007.05.060Search in Google Scholar

United States Pharmacopoeia 24, National Formulary 19, USP Pharmacopoeial Convention, Rockwille (MD) 2000.Search in Google Scholar

ICH Topic Q1 A (R2) Stability Testing of new Drug Substances and Products (2005), International Conference on Harmonisation of Technical requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland.Search in Google Scholar

B. J. Vermeer, Skin irritation and sensitization, J. Control. Rel. 15 (1991) 261-265; DOI: 10.1016/0168-3659(91)90117-V.10.1016/0168-3659(91)90117-VSearch in Google Scholar

E. Pontiki and D. Hadjipavlou-Litina, Synthesis of phenyl-substituted amides with antioxidant and anti-inflammatory activity as novel lipoxygenase inhibitors, Med. Chem. 3 (2007) 175-186; DOI: 10.2174/157340607780059512.10.2174/15734060778005951217348855Search in Google Scholar

M. D. Joshi and V. B. Patravale, Formulation and evaluation of nanostructured lipid carrier (NLC) based gel of valdecoxib, Drug Dev. Ind. Pharm. 32 (2006) 911-918; DOI: 10.1080/03639040600814676.10.1080/0363904060081467616954103Search in Google Scholar

R. Sanghavi, R. Narazaki, S. G. Machatha and S. H. Yalkowsky, Solubility improvement of drugs using N-methyl pyrrolidone, AAPS PharmSci Tech. 9 (2008) 366-376; DOI: 10.1208/s12249-008-9050-z.10.1208/s12249-008-9050-z297693518431671Search in Google Scholar

P. J. Lee, R. Langer and V. P. Shastri, Role of N-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport, J. Pharm. Sci. 94 (2005) 912-917; DOI: 10.1002/jps.20291.10.1002/jps.2029115736187Search in Google Scholar

A. C. Williams and B. W. Barry, Penetration enhancers, Adv. Drug Del. Rev. 56 (2004) 603-618; DOI:10.1016/j.addr.2003.10.025.10.1016/j.addr.2003.10.02515019749Search in Google Scholar